Summary of Significant Accounting Policies - Orthobiologics Business (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Nov. 08, 2023 |
Jun. 30, 2024 |
Dec. 31, 2023 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Summary of Significant Accounting Policies | |||||
| Proceeds from sale of Orthobiologics Business | $ 425 | ||||
| Divestiture of Orthobiologics | Discontinued Operations, Disposed of by Sale | |||||
| Summary of Significant Accounting Policies | |||||
| Proceeds from sale of Orthobiologics Business | $ 14,600 | ||||
| Additional amount that may be earned | $ 20,000 | ||||
| Earn-out payments, as a percent actual revenue | 10.00% | ||||
| Earn-out period | 5 years | ||||
| Earn-out payments received | 0 | $ 0 | |||
| Recognized a gain | $ 200 | $ 6,000 | |||
| Indemnity holdback amount | $ 1,500 | ||||
| Retainment Period | 24 months | ||||
| Indemnity holdback amount resolved and received | $ 400 | ||||